This study investigated the biotransformation of the dicarboximide fungicid
e vinclozolin [3-(3,5-dichlorophenyl)-5-methyl-5-vinyl-1,3-oxazolidine-2,4-
dione] by the fungus Cunninghamella elegans. Experiments with phenyl-[U-rin
g-C-14]vinclozolin showed that after 96 h incubation, 93% had been transfor
med to four major metabolites. Metabolites were separated by HPLC and chara
cterized by mass and NMR spectroscopy. Biotransformation occurred predomina
ntly on the oxazolidine-2,4-dione portion of vinclozolin. The metabolites w
ere identified as the 3R- and 3S- isomers of 3',5'-dichloro-2,3,4-trihydrox
y-2- methylbutyranilide, N-(2-hydroxy-2-methyl-1-oxobuten-3-yl)-3,5-dichlo-
rophenyl-1-carbamic acid, and 3',5'-dichloro-2-hydroxy-2-methylbut-3-enanil
ide. The enanilide compound has been reported previously as a plant and mam
malian metabolite and is implicated to contain antiandrogenic activity. The
3R- and 3S- isomers of 3',5'-dichloro-2,3,4-trihydroxy-2-methylbutyranilid
e are novel metabolites.